<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02400047</url>
  </required_header>
  <id_info>
    <org_study_id>35RC14_9853_DEXA OP</org_study_id>
    <secondary_id>2014-005026-35</secondary_id>
    <secondary_id>141557A-32</secondary_id>
    <nct_id>NCT02400047</nct_id>
  </id_info>
  <brief_title>Dexamethasone, Can it Replace Ketoprofen in the Strategy of Intraoperative Multimodal Analgesia in Paediatric Surgery ? A Prospective Randomized Double-blinded Study. DEXA OP</brief_title>
  <acronym>DEXA OP</acronym>
  <official_title>Dexamethasone, Can it Replace Ketoprofen in the Strategy of Intraoperative Multimodal Analgesia in Paediatric Surgery ? A Prospective Randomized Double-blinded Study. DEXA OP</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rennes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Postoperative pain and nausea-vomiting (PONV) are the first causes of failure in ambulatory
      care in pediatric surgery. Actually, the paracetamol/ketoprofen combination in intraoperative
      care is recommended for effective postoperative analgesia in children. However, intravenous
      ketoprofen doesn't have the marketing authorization for use in children less than 15 years
      old and its use is mainly justified by the absence of therapeutic alternatives. Recently,
      findings from published studies suggest that dexamethasone (DXM), which is actually
      recommended to prevent PONV for children &quot;at risk&quot;, at a dose of 0.1mg/kg, would have
      analgesic properties above 0.15 mg/kg comparable to non-steroidal anti-inflammatories (NSAI).

      Main objective :

      To examine the effects of intraoperative DXM (0.2mg/kg and 0.4mg/kg) on the intensity of
      postoperative pain in the post-anaesthetic care unit (PACU) compared to ketoprofen (1mg/kg).

      Secondary objectives :

      To examine the effects of intraoperative DXM (0.2mg/kg and 0.4mg/kg) compared to ketoprofen
      (1mg/kg) on the anesthesia emergence delirium, the intensity of postoperative pain, the
      consumption of rescue analgesics and the side effects in the first 24 hours after surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Methodology :

      Non inferiority, phase III, therapeutic trial. Prospective, randomized double-blinded,
      monocentric study. Inclusion of 567 patients. Inclusion will be performed by the
      anesthesiologist, the day of surgery during the preoperative visit.

      Each patient will be randomised to receive intraoperative DXM (0.2mg/kg), DXM (0.4mg/kg) (max
      20mg) or ketoprofen (1mg/kg) (max 100mg).

      The clinical data will be collected prospectively in an electronic database. If the
      hypothesis of non-inferiority is verified, it is planned to test the superiority of the
      hypothesis secondarily.

      Treatment :

      Single injection of DXM (Mylan Dexamethasone® 20 mg/5 ml or 4 mg/1 ml injection ampoule
      solution) at 0.2 mg / kg or 0.4 mg/kg or single injection of ketoprofen (Medac ketoprofen ®
      100 mg/4 ml injection ampoule solution) at 1 mg /kg after general anesthesia induction and
      before surgery incision.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Maximum intensity of postoperative pain</measure>
    <time_frame>1 hour</time_frame>
    <description>Maximum intensity of postoperative pain assessed in PACU using the Faces Legs Activity Cry Consolability tool (FLACC, 0-10)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pediatric Anesthesia Emergence Delirium Scale (PAEDS)</measure>
    <time_frame>24 hours</time_frame>
    <description>Pediatric Anesthesia Emergence Delirium Scale (PAEDS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intensity of postoperative pain</measure>
    <time_frame>24 hours</time_frame>
    <description>Intensity of postoperative pain assessed in ambulatory unit and at home one day after surgery. (FLACC, 0-10).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rescue analgesic consumption</measure>
    <time_frame>24 hours</time_frame>
    <description>Rescue analgesic consumption in the PACU, ambulatory unit and at home.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Side effects</measure>
    <time_frame>24 hours</time_frame>
    <description>Side effects during hospitalization (PONV, postoperative bleeding) and in the first 24 hours post-surgery (PONV, fever, bleeding, behavior modification and sleep disorders).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay</measure>
    <time_frame>24 hours</time_frame>
    <description>Length of stay in ambulatory unit (time of possible discharge using Pediatric Post Anesthetic Discharge Scoring System and the actual time of discharge).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Parent's satisfaction</measure>
    <time_frame>24 hours</time_frame>
    <description>Parent's satisfaction on a four-point Likert scale</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">567</enrollment>
  <condition>Postoperative Nausea and Vomiting</condition>
  <arm_group>
    <arm_group_label>Dexamethasone 0.2 mg/kg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single injection of DXM (Mylan Dexamethasone® 20 mg/5 ml or 4 mg/1 ml injection ampoule solution) at 0.2 mg / kg after general anesthesia induction and before surgery incision.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexamethasone 0.4 mg/kg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single injection of DXM (Mylan Dexamethasone® 20 mg/5 ml or 4 mg/1 ml injection ampoule solution) at 0.4 mg / kg after general anesthesia induction and before surgery incision.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ketoprofen 1 mg/kg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Single injection of ketoprofen (Medac ketoprofen ® 100 mg/4 ml injection ampoule solution) at 1 mg /kg after general anesthesia induction and before surgery incision.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone 0.2 mg/kg</intervention_name>
    <description>Single injection of DXM (Mylan Dexamethasone® 20 mg/5 ml or 4 mg/1 ml injection ampoule solution) at 0.2 mg / kg after general anesthesia induction and before surgery incision.</description>
    <arm_group_label>Dexamethasone 0.2 mg/kg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone 0.4 mg/kg</intervention_name>
    <description>Single injection of DXM (Mylan Dexamethasone® 20 mg/5 ml or 4 mg/1 ml injection ampoule solution) at 0.4 mg / kg after general anesthesia induction and before surgery incision.</description>
    <arm_group_label>Dexamethasone 0.4 mg/kg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketoprofen 1 mg/kg</intervention_name>
    <description>Single injection of ketoprofen (Medac ketoprofen ® 100 mg/4 ml injection ampoule solution) at 1 mg /kg after general anesthesia induction and before surgery incision.</description>
    <arm_group_label>Ketoprofen 1 mg/kg</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children, aged 1 to 16 years

          -  Undergoing surgery (orchiopexy, inguinal hernia, circumcision, adenoidectomy,
             tonsillectomy or orthopedic act with osteosynthesis)

          -  Parental consent

        Exclusion Criteria:

          -  Contraindication to NSAI or DXM

          -  Hypersensitivity to ketoprofen, DXM, hypnovel or atarax

          -  Porphyria

          -  Long QT Syndrome

          -  Renal or hepatic impairment

          -  Corticosteroid consumption the week before surgery

          -  NSAI consumption within 48 hours before surgery

          -  IV induction for full stomach or myopathic patient.

          -  French language not spoken by parents.

          -  Simultaneous participation in biomedical research on health products
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nicolas Nardi, MD</last_name>
    <email>nicolas.nardi@chu-rennes.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Eric Wodey, MD</last_name>
    <email>erci.wodey@chu-rennes.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Rennes University Hospital</name>
      <address>
        <city>Rennes</city>
        <state>Brittany</state>
        <zip>35000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicolas Nardi, MD</last_name>
      <email>nicolas.nardi@chu-rennes.fr</email>
    </contact>
    <investigator>
      <last_name>Nicolas Nardi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eric Wodey, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 23, 2015</study_first_submitted>
  <study_first_submitted_qc>March 25, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 26, 2015</study_first_posted>
  <last_update_submitted>April 6, 2018</last_update_submitted>
  <last_update_submitted_qc>April 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Paediatric surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vomiting</mesh_term>
    <mesh_term>Postoperative Nausea and Vomiting</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Ketoprofen</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

